Comparison of baseline covariate adjustment methods for restricted mean survival time

The restricted mean survival time provides a straightforward clinical measure that dispenses with the need for proportional hazards assumptions. We focus on two strategies to directly model the survival time and adjust covariates. Firstly, pseudo-survival time is calculated for each subject using a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Contemporary clinical trials 2024-03, Vol.138, p.107440-107440, Article 107440
Hauptverfasser: Hanada, Keisuke, Moriya, Junji, Kojima, Masahiro
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 107440
container_issue
container_start_page 107440
container_title Contemporary clinical trials
container_volume 138
creator Hanada, Keisuke
Moriya, Junji
Kojima, Masahiro
description The restricted mean survival time provides a straightforward clinical measure that dispenses with the need for proportional hazards assumptions. We focus on two strategies to directly model the survival time and adjust covariates. Firstly, pseudo-survival time is calculated for each subject using a leave-one-out approach, followed by a model analysis that adjusts for covariates using all pseudo-values. This method is used to reflect information of censored subjects in the model analysis. The second approach adjusts for covariates for those subjects with observed time-to-event while incorporating censored subjects using inverse probability of censoring weighting (IPCW). This paper evaluates these methods' power to detect group differences through computer simulations. We find the interpretation of pseudo-values challenging with the pseudo-survival time method and confirm that pseudo-survival times deviate from actual data in a primary biliary cholangitis clinical trial, mainly due to extensive censoring. Simulations reveal that the IPCW method is more robust, unaffected by the balance of censors, whereas pseudo-survival time is influenced by this balance. The IPCW method retains a nominal significance level for the type-1 error rate, even amidst group differences concerning censor incidence rates and covariates. Our study concludes that IPCW and pseudo-survival time methods differ significantly in handling censored data, impacting parameter estimations. Our findings suggest that the IPCW method provides more robust results than pseudo-survival time and is recommended, even when censor probabilities vary between treatment groups. However, pseudo-survival time remains a suitable choice when censoring probabilities are balanced.
doi_str_mv 10.1016/j.cct.2024.107440
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2915991578</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1551714424000144</els_id><sourcerecordid>2915991578</sourcerecordid><originalsourceid>FETCH-LOGICAL-c305t-c27f20ef155bdceb7970649f1bf4aebcbd1ce7531f1c2ff393130e7a9748baf43</originalsourceid><addsrcrecordid>eNp9kE1LAzEQhoMotlZ_gBfJ0cvWfG3TxZMUv6DgxZ5DNjvBlN1NTbIL_ntTWz16GOaDd15mHoSuKZlTQhd327kxac4IE7mXQpATNKVlWRWMcHL6U9NCUiEm6CLGLSF8US7KczThS8aWjLMp2qx8t9PBRd9jb3GtI7SuB2z8mKc6AdbNdoipgz7hDtKHbyK2PuAAMQVnEjR5rHschzC6Ubc4uQ4u0ZnVbYSrY56hzdPj--qlWL89v64e1oXhpEyFYdIyAjbfWTcGallJshCVpbUVGmpTN9SALDm11DBrecUpJyB1JcWy1lbwGbo9-O6C_xzyRapz0UDb6h78EBWraFnlkMsspQepCT7GAFbtgut0-FKUqD1NtVWZptrTVAeaeefmaD_UHTR_G7_4suD-IID85OggqGgc9AYaFyCbNd79Y_8NlYqGsg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2915991578</pqid></control><display><type>article</type><title>Comparison of baseline covariate adjustment methods for restricted mean survival time</title><source>Elsevier ScienceDirect Journals Complete</source><creator>Hanada, Keisuke ; Moriya, Junji ; Kojima, Masahiro</creator><creatorcontrib>Hanada, Keisuke ; Moriya, Junji ; Kojima, Masahiro</creatorcontrib><description>The restricted mean survival time provides a straightforward clinical measure that dispenses with the need for proportional hazards assumptions. We focus on two strategies to directly model the survival time and adjust covariates. Firstly, pseudo-survival time is calculated for each subject using a leave-one-out approach, followed by a model analysis that adjusts for covariates using all pseudo-values. This method is used to reflect information of censored subjects in the model analysis. The second approach adjusts for covariates for those subjects with observed time-to-event while incorporating censored subjects using inverse probability of censoring weighting (IPCW). This paper evaluates these methods' power to detect group differences through computer simulations. We find the interpretation of pseudo-values challenging with the pseudo-survival time method and confirm that pseudo-survival times deviate from actual data in a primary biliary cholangitis clinical trial, mainly due to extensive censoring. Simulations reveal that the IPCW method is more robust, unaffected by the balance of censors, whereas pseudo-survival time is influenced by this balance. The IPCW method retains a nominal significance level for the type-1 error rate, even amidst group differences concerning censor incidence rates and covariates. Our study concludes that IPCW and pseudo-survival time methods differ significantly in handling censored data, impacting parameter estimations. Our findings suggest that the IPCW method provides more robust results than pseudo-survival time and is recommended, even when censor probabilities vary between treatment groups. However, pseudo-survival time remains a suitable choice when censoring probabilities are balanced.</description><identifier>ISSN: 1551-7144</identifier><identifier>EISSN: 1559-2030</identifier><identifier>DOI: 10.1016/j.cct.2024.107440</identifier><identifier>PMID: 38228232</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Inverse probability of censoring weighting ; Restricted mean survival time</subject><ispartof>Contemporary clinical trials, 2024-03, Vol.138, p.107440-107440, Article 107440</ispartof><rights>2024 Elsevier Inc.</rights><rights>Copyright © 2024 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c305t-c27f20ef155bdceb7970649f1bf4aebcbd1ce7531f1c2ff393130e7a9748baf43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1551714424000144$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3536,27903,27904,65309</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38228232$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hanada, Keisuke</creatorcontrib><creatorcontrib>Moriya, Junji</creatorcontrib><creatorcontrib>Kojima, Masahiro</creatorcontrib><title>Comparison of baseline covariate adjustment methods for restricted mean survival time</title><title>Contemporary clinical trials</title><addtitle>Contemp Clin Trials</addtitle><description>The restricted mean survival time provides a straightforward clinical measure that dispenses with the need for proportional hazards assumptions. We focus on two strategies to directly model the survival time and adjust covariates. Firstly, pseudo-survival time is calculated for each subject using a leave-one-out approach, followed by a model analysis that adjusts for covariates using all pseudo-values. This method is used to reflect information of censored subjects in the model analysis. The second approach adjusts for covariates for those subjects with observed time-to-event while incorporating censored subjects using inverse probability of censoring weighting (IPCW). This paper evaluates these methods' power to detect group differences through computer simulations. We find the interpretation of pseudo-values challenging with the pseudo-survival time method and confirm that pseudo-survival times deviate from actual data in a primary biliary cholangitis clinical trial, mainly due to extensive censoring. Simulations reveal that the IPCW method is more robust, unaffected by the balance of censors, whereas pseudo-survival time is influenced by this balance. The IPCW method retains a nominal significance level for the type-1 error rate, even amidst group differences concerning censor incidence rates and covariates. Our study concludes that IPCW and pseudo-survival time methods differ significantly in handling censored data, impacting parameter estimations. Our findings suggest that the IPCW method provides more robust results than pseudo-survival time and is recommended, even when censor probabilities vary between treatment groups. However, pseudo-survival time remains a suitable choice when censoring probabilities are balanced.</description><subject>Inverse probability of censoring weighting</subject><subject>Restricted mean survival time</subject><issn>1551-7144</issn><issn>1559-2030</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNp9kE1LAzEQhoMotlZ_gBfJ0cvWfG3TxZMUv6DgxZ5DNjvBlN1NTbIL_ntTWz16GOaDd15mHoSuKZlTQhd327kxac4IE7mXQpATNKVlWRWMcHL6U9NCUiEm6CLGLSF8US7KczThS8aWjLMp2qx8t9PBRd9jb3GtI7SuB2z8mKc6AdbNdoipgz7hDtKHbyK2PuAAMQVnEjR5rHschzC6Ubc4uQ4u0ZnVbYSrY56hzdPj--qlWL89v64e1oXhpEyFYdIyAjbfWTcGallJshCVpbUVGmpTN9SALDm11DBrecUpJyB1JcWy1lbwGbo9-O6C_xzyRapz0UDb6h78EBWraFnlkMsspQepCT7GAFbtgut0-FKUqD1NtVWZptrTVAeaeefmaD_UHTR_G7_4suD-IID85OggqGgc9AYaFyCbNd79Y_8NlYqGsg</recordid><startdate>20240301</startdate><enddate>20240301</enddate><creator>Hanada, Keisuke</creator><creator>Moriya, Junji</creator><creator>Kojima, Masahiro</creator><general>Elsevier Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20240301</creationdate><title>Comparison of baseline covariate adjustment methods for restricted mean survival time</title><author>Hanada, Keisuke ; Moriya, Junji ; Kojima, Masahiro</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c305t-c27f20ef155bdceb7970649f1bf4aebcbd1ce7531f1c2ff393130e7a9748baf43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Inverse probability of censoring weighting</topic><topic>Restricted mean survival time</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hanada, Keisuke</creatorcontrib><creatorcontrib>Moriya, Junji</creatorcontrib><creatorcontrib>Kojima, Masahiro</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Contemporary clinical trials</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hanada, Keisuke</au><au>Moriya, Junji</au><au>Kojima, Masahiro</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Comparison of baseline covariate adjustment methods for restricted mean survival time</atitle><jtitle>Contemporary clinical trials</jtitle><addtitle>Contemp Clin Trials</addtitle><date>2024-03-01</date><risdate>2024</risdate><volume>138</volume><spage>107440</spage><epage>107440</epage><pages>107440-107440</pages><artnum>107440</artnum><issn>1551-7144</issn><eissn>1559-2030</eissn><abstract>The restricted mean survival time provides a straightforward clinical measure that dispenses with the need for proportional hazards assumptions. We focus on two strategies to directly model the survival time and adjust covariates. Firstly, pseudo-survival time is calculated for each subject using a leave-one-out approach, followed by a model analysis that adjusts for covariates using all pseudo-values. This method is used to reflect information of censored subjects in the model analysis. The second approach adjusts for covariates for those subjects with observed time-to-event while incorporating censored subjects using inverse probability of censoring weighting (IPCW). This paper evaluates these methods' power to detect group differences through computer simulations. We find the interpretation of pseudo-values challenging with the pseudo-survival time method and confirm that pseudo-survival times deviate from actual data in a primary biliary cholangitis clinical trial, mainly due to extensive censoring. Simulations reveal that the IPCW method is more robust, unaffected by the balance of censors, whereas pseudo-survival time is influenced by this balance. The IPCW method retains a nominal significance level for the type-1 error rate, even amidst group differences concerning censor incidence rates and covariates. Our study concludes that IPCW and pseudo-survival time methods differ significantly in handling censored data, impacting parameter estimations. Our findings suggest that the IPCW method provides more robust results than pseudo-survival time and is recommended, even when censor probabilities vary between treatment groups. However, pseudo-survival time remains a suitable choice when censoring probabilities are balanced.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>38228232</pmid><doi>10.1016/j.cct.2024.107440</doi><tpages>1</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1551-7144
ispartof Contemporary clinical trials, 2024-03, Vol.138, p.107440-107440, Article 107440
issn 1551-7144
1559-2030
language eng
recordid cdi_proquest_miscellaneous_2915991578
source Elsevier ScienceDirect Journals Complete
subjects Inverse probability of censoring weighting
Restricted mean survival time
title Comparison of baseline covariate adjustment methods for restricted mean survival time
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T10%3A13%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Comparison%20of%20baseline%20covariate%20adjustment%20methods%20for%20restricted%20mean%20survival%20time&rft.jtitle=Contemporary%20clinical%20trials&rft.au=Hanada,%20Keisuke&rft.date=2024-03-01&rft.volume=138&rft.spage=107440&rft.epage=107440&rft.pages=107440-107440&rft.artnum=107440&rft.issn=1551-7144&rft.eissn=1559-2030&rft_id=info:doi/10.1016/j.cct.2024.107440&rft_dat=%3Cproquest_cross%3E2915991578%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2915991578&rft_id=info:pmid/38228232&rft_els_id=S1551714424000144&rfr_iscdi=true